Moderna MRNA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $389M-42.6% | $678M-33.3% | $1.02B+615% | $142M+31.5% | $108M-88.8% | ||
| $955M+111% | $452M+118% | $207M+73.9% | $119M+32.2% | $90M-87.8% | ||
| -$566M-350% | $226M-72.1% | $809M+3,417% | $23M+27.8% | $18M-92.1% | ||
| -145.5%-179pp | 33.3%-46.3pp | 79.6%+63.4pp | 16.2%-0.5pp | 16.7%-6.8pp | ||
| $649M-16.3% | $775M-3.2% | $801M+14.4% | $700M-18.2% | $856M-23.7% | ||
| $173M-43.8% | $308M+14.9% | $268M+16.5% | $230M+8.5% | $212M-39.6% | ||
| $1.78B+15.8% | $1.54B+20.3% | $1.28B+21.6% | $1.05B-9.4% | $1.16B-47.6% | ||
| -$1.39B-62.0% | -$857M-230% | -$260M+71.3% | -$907M+13.6% | -$1.05B+15.7% | ||
| -356.8%-230pp | -126.4%-101pp | -25.6%+613pp | -638.7%+333pp | -972.2%-843pp | ||
| -$18M-50.0% | -$12M— | $0-100% | $8M+300% | -$4M+86.2% | ||
| -$1.33B-67.0% | -$799M-327% | -$187M+77.1% | -$818M+15.1% | -$964M+18.6% | ||
| $9M-66.7% | $27M+108% | $13M+85.7% | $7M0.0% | $7M+111% | ||
| -$1.34B-62.6% | -$826M-313% | -$200M+75.8% | -$825M+15.0% | -$971M+13.3% | ||
| -345.2%-223pp | -121.8%-102pp | -19.7%+561pp | -581%+318pp | -899.1%-783pp | ||
| -$3.40-61.1% | -$2.11-314% | -$0.51+76.1% | -$2.13+15.5% | -$2.52+13.4% | ||
| -$1.33B-68.2% | -$790M-280% | -$208M+75.5% | -$850M+15.9% | -$1.01B+14.8% | ||
| -341.6%-225pp | -116.5%-96.0pp | -20.5%+578pp | -598.6%+338pp | -936.1%-813pp | ||
| -$1.39B-62.0% | -$857M-230% | -$260M+71.3% | -$907M+13.6% | -$1.05B+15.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Moderna's revenue?
- Moderna (MRNA) generated $2.2B in revenue over the trailing twelve months, down 30.0% year over year.
- Is Moderna profitable?
- Moderna is not currently profitable: it reported a net loss of $3.2B over the trailing twelve months, a -143.6% net margin.
- What are Moderna's profit margins?
- Gross margin is 22.1% and operating margin is -153.3%, with a -143.6% net margin.
- What is Moderna's earnings per share?
- Moderna's diluted EPS over the trailing twelve months is $-8.15.
- Where does Moderna's income statement data come from?
- Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
